Tag Archives: ZYN002

Up in Smoke: Zynerba Pharmaceuticals Lost More Than Half Its Value

Up in Smoke: Zynerba Pharmaceuticals Lost More Than Half Its Value

Up in Smoke: Zynerba Pharmaceuticals Lost More Than Half Its Value

Clinical-stage cannabinoid-based drug developer Zynerba Pharmaceuticals (NASDAQ:ZYNE) had been one of the strongest-performing pot stocks over the trailing year prior to the start of this past week.

5 Things You Need to Know About Marijuana Stock Zynerba Pharmaceuticals

5 Things You Need to Know About Marijuana Stock Zynerba Pharmaceuticals

There are three different general types of marijuana stocks on the market. Some are marijuana growers. Others provide supplies to marijuana growers. Then there’s the third type: the biotechs. Zynerba Pharmaceuticals belongs to the last kind of marijuana stock.

Zynerba

Zynerba Pharmaceuticals Reports First Quarter 2016 Financial Results and Operational Highlights

DEVON, Pa., May 12, 2016 /Weed Wire/ — Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today reported financial results for the quarter ended March 31, 2016, and provided an overview of recent operational highlights.


Top